Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glioma Glioblastoma Multiforme”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT03152708
What this trial is testing

CAN008 Biomarker CD95 Ligand and CpG2 Methylation in Chinese Patients With Glioblastoma

Who this might be right for
Glioblastoma
CANbridge Life Sciences Ltd. 62
Very early researchStudy completedNCT03360708
What this trial is testing

Vaccine Therapy in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Giant Cell GlioblastomaRecurrent GlioblastomaRecurrent Gliosarcoma
Mayo Clinic 20
Testing effectiveness (Phase 2)Study completedNCT02968940
What this trial is testing

Avelumab With Hypofractionated Radiation Therapy in Adults With Isocitrate Dehydrogenase (IDH) Mutant Glioblastoma

Who this might be right for
Glioblastoma
NYU Langone Health 6
Testing effectiveness (Phase 2)UnknownNCT04888611
What this trial is testing

Neoadjuvant PD-1 Antibody Alone or Combined With DC Vaccines for Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Huashan Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT01351519
What this trial is testing

Aminolevulinic Acid Used to Enhance Visualization and Surgical Removal of Brain Tumors

Who this might be right for
Malignant GliomaGliomaGlioblastoma+2 more
MultiCare Health System Research Institute 16
Testing effectiveness (Phase 2)WithdrawnNCT04629209
What this trial is testing

A Phase II, Open Label Study of ONC201 in Adults With EGFR-low Glioblastoma

Who this might be right for
Glioblastoma
Masonic Cancer Center, University of Minnesota
Testing effectiveness (Phase 2)Ended earlyNCT01966809
What this trial is testing

Photodynamic Therapy (PDT) For Recurrent High Grade Gliomas

Who this might be right for
Brain Tumor, Recurrent
Harry T Whelan, MD 1
Large-scale testing (Phase 3)UnknownNCT01308632
What this trial is testing

Metronomic Temozolamide in Patients With Recurrent Glioblastoma

Who this might be right for
Glioblastoma
Grupo Español de Investigación en Neurooncología 30
Early research (Phase 1)Study completedNCT02654964
What this trial is testing

Cancer Stem Cell High-Throughput Drug Screening Study

Who this might be right for
Glioblastoma Multiforme
Swedish Medical Center 9
Testing effectiveness (Phase 2)Study completedNCT00362921
What this trial is testing

Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Recurrent Adult Brain Tumor
Duke University 52
Early research (Phase 1)Active Not RecruitingNCT03389230
What this trial is testing

Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma

Who this might be right for
GlioblastomaMalignant GliomaRecurrent Glioma+2 more
City of Hope Medical Center 29
Testing effectiveness (Phase 2)Study completedNCT04492163
What this trial is testing

Open-Label Pilot Study of OPTUNE® With High Density Transducer Arrays for the Treatment of Recurrent GBM

Who this might be right for
Glioblastoma Multiforme
NovoCure GmbH 25
Early research (Phase 1)Study completedNCT01119599
What this trial is testing

RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma

Who this might be right for
Acoustic SchwannomaAdult Anaplastic (Malignant) MeningiomaAdult Anaplastic Astrocytoma+26 more
National Cancer Institute (NCI) 22
Early research (Phase 1)Ended earlyNCT02664363
What this trial is testing

EGFRvIII CAR T Cells for Newly-Diagnosed WHO Grade IV Malignant Glioma

Who this might be right for
GlioblastomaGliosarcoma
Daniel Landi 3
Testing effectiveness (Phase 2)Study completedNCT00099060
What this trial is testing

Lapatinib in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Looking for participantsNCT05683808
What this trial is testing

Venous Thromboembolism Prevention in Outpatients With Glioma

Who this might be right for
GlioblastomaAstrocytomaVenous Thromboembolism
University of Vermont Medical Center 40
Testing effectiveness (Phase 2)Study completedNCT01478178
What this trial is testing

Safety Study of VAL-083 in Patients With Recurrent Malignant Glioma

Who this might be right for
GliomaGlioblastomaGlioblastoma Multiforme+2 more
Kintara Therapeutics, Inc. 55
Early research (Phase 1)Study completedNCT03726515
What this trial is testing

CART-EGFRvIII + Pembrolizumab in GBM

Who this might be right for
Glioblastoma
University of Pennsylvania 7
Not applicableLooking for participantsNCT06273176
What this trial is testing

The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma

Who this might be right for
Glioblastoma, IDH-wildtypeGlioblastomaGlioblastoma Multiforme of Brain+6 more
Erasmus Medical Center 225
Testing effectiveness (Phase 2)Study completedNCT04743310
What this trial is testing

Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas System

Who this might be right for
Central Nervous System Tumor
John Yu 50
Next Page